2019•Zhongguo jiceng yiyaoRequires access

Effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal tumor

Wei-Ping Ma, Jinli Li

Open publisher page 0 citations

Abstract

Objective To observe the effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal cancer. Methods From January 2014 to January 2017, 100 patients with gastrointestinal cancer in Yuncheng Central Hospital were selected in the research and randomly divided into two groups according to the digital table, with 50 cases in each group.All the patients underwent chemotherapy, the observation group was given enteral nutritional emulsion during chemotherapy.The indicators of nutritional status, immune function, the effect of chemotherapy, the incidence of adverse reactions were compared between the two groups. Results After treatment, the prealbumin, albumin, transferrin and hemoglobin levels in the observation group were (0.30±0.07)g/L, (32.93±1.67)g/L, (2.61±0.15)g/L, (109.94±2.31)g/L, respectively, which in the control group were (0.19±0.09)g/L, (30.89±1.49)g/L, (2.49±0.14)g/L, (108.07±2.04)g/L, respectively, there were statistically significant differences between the two groups(t=6.822, 6.445, 4.135, 4.291, all P<0.05). After treatment, the CD3+ , CD4/CD8, NK cells in the observation group were (43.84±7.65)%, (1.70±0.18) and (37.78±7.51)%, respectively, which in the control group were (36.12±6.57)%, (1.52±0.19) and (31.07±4.20)%, respectively, there were statistically significant differences between the two groups(t=5.413, 4.863, 6.124, all P<0.05). The objective response rate of the observation group (64%) was significantly higher than that of the control group(44%)(χ2=4.026, P<0.05). The incidence rate of adverse reaction of the observation group (18%) was significantly lower than that of the control group(36%)(χ2=4.110, P<0.05). Conclusion Enteral nutritional emulsion can effectively improve the nutritional status and immune function of patients with gastrointestinal cancer during chemotherapy, but also can effectively enhance sensitivity to chemotherapy, improve the effect of chemotherapy, and the safety is reliable. Key words: Gastrointestinal neoplasms; Gastrointestinal neoplasms; Fat emulsions, intravenous; Parenteral nutrition; Immune function; Nutritional status

About this research paper

What this paper is about

Objective To observe the effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal cancer. Methods From January 2014 to January 2017, 100 patients with gastrointestinal cancer in Yuncheng Central Hospital were selected in the research and randomly divided into two groups according to the digital table, with 50 cases in each group.All the patients underwent chemotherapy, the observation group was given enteral nutritional emulsion during chemotherapy.The indicators of nutritional status, immune function, the effect of chemotherapy, the incidence of adverse reactions were compared between the two groups. Results After treatment, the prealbumin, albumin, transferrin and hemoglobin levels in the observation group were (0.30±0.07)g/L, (32.93±1.67)g/L, (2.61±0.15)g/L, (109.94±2.31)g/L, respectively, which in the control group were (0.19±0.09)g/L, (30.89±1.49)g/L, (2.49±0.14)g/L, (108.07±2.04)g/L, respectively, there were statistically significant differences between the two groups(t=6.822, 6.445, 4.135, 4.291, all P<0.05). After treatment, the CD3+ , CD4/CD8, NK cells in the observation group were (43.84±7.65)%, (1.70±0.18) and (37.78±7.51)%, respectively, which in the control group were (36.12±6.57)%, (1.52±0.19) and (31.07±4.20)%, respectively, there were statistically significant differences between the two groups(t=5.413, 4.863, 6.124, all P<0.05). The objective response rate of the observation group (64%) was significantly higher than that of the control group(44%)(χ2=4.026, P<0.05). The incidence rate of adverse reaction of the observation group (18%) was significantly lower than that of the control group(36%)(χ2=4.110, P<0.05). Conclusion Enteral nutritional emulsion can effectively improve the nutritional status and immune function of patients with gastrointestinal cancer during chemotherapy, but also can effectively enhance sensitivity to chemotherapy, improve the effect of chemotherapy, and the safety is reliable. Key words: Gastrointestinal neoplasms; Gastrointestinal neoplasms; Fat emulsions, intravenous; Parenteral nutrition; Immune function; Nutritional status

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal cancer. Methods From January 2014 to January 2017, 100 patients with gastrointestinal cancer in Yuncheng Central Hospital were selected in the research and randomly divided into two groups according to the digital table, with 50 cases in each group.All the patients underwent chemotherapy, the observation group was given enteral nutritional emulsion during chemotherapy.The indicators of nutritional status, immune function, the effect of chemotherapy, the incidence of adverse reactions were compared between the two groups. Results After treatment, the prealbumin, albumin, transferrin and hemoglobin levels in the observation group were (0.30±0.07)g/L, (32.93±1.67)g/L, (2.61±0.15)g/L, (109.94±2.31)g/L, respectively, which in the control group were (0.19±0.09)g/L, (30.89±1.49)g/L, (2.49±0.14)g/L, (108.07±2.04)g/L, respectively, there were statistically significant differences between the two groups(t=6.822, 6.445, 4.135, 4.291, all P<0.05). After treatment, the CD3+ , CD4/CD8, NK cells in the observation group were (43.84±7.65)%, (1.70±0.18) and (37.78±7.51)%, respectively, which in the control group were (36.12±6.57)%, (1.52±0.19) and (31.07±4.20)%, respectively, there were statistically significant differences between the two groups(t=5.413, 4.863, 6.124, all P<0.05). The objective response rate of the observation group (64%) was significantly higher than that of the control group(44%)(χ2=4.026, P<0.05). The incidence rate of adverse reaction of the observation group (18%) was significantly lower than that of the control group(36%)(χ2=4.110, P<0.05). Conclusion Enteral nutritional emulsion can effectively improve the nutritional status and immune function of patients with gastrointestinal cancer during chemotherapy, but also can effectively enhance sensitivity to chemotherapy, improve the effect of chemotherapy, and the safety is reliable. Key words: Gastrointestinal neoplasms; Gastrointestinal neoplasms; Fat emulsions, intravenous; Parenteral nutrition; Immune function; Nutritional status

Key concepts: Medicine, Gastroenterology, Internal medicine, Enteral administration, Chemotherapy, Incidence (geometry), Parenteral nutrition, Gastrointestinal cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of enteral nutritional emulsion on nutritional status and immune function in patients with gastrointestinal tumor — Research Paper | ScholarLens